A Bone Drug That Treats Baldness?

TUESDAY, May 8, 2018 (HealthDay News) — A drug intended as a treatment for osteoporosis may help treat hair loss, researchers say. “The fact this new agent, which had never even been considered in a hair loss context, promotes human hair growth is exciting because of its translational potential: It could one day make a…

More Americans DOA From Gun, Knife Wounds

TUESDAY, May 8, 2018 (HealthDay News) — Victims of gunshots or stabbings are much more likely to die before arriving at U.S. trauma centers than 10 years ago. This suggests the intensity of violence is increasing, a new study contends. “The data we found suggest that a greater proportion of patients injured by penetrating trauma…

Non-Opioids Often Underused After Back Surgery

TUESDAY, May 8, 2018 (HealthDay News) — Spine and joint surgery patients aren’t taking advantage of common pain relievers like Tylenol or Motrin during their recovery, researchers say. Instead, many are given opioids, such as oxycodone (OxyContin) or hydrocodone (Vicodin). These highly addictive narcotics are potentially deadly when abused. The United States is currently grappling…

How Fire-Safe Is Your Airbnb?

TUESDAY, May 8, 2018 (HealthDay News) — If you use Airbnbs or other vacation rentals, it might be a good idea to check first on their fire safety. A new study found that while many Airbnbs in the United States had smoke alarms, less than half had fire extinguishers or first-aid kits. The research was…

Is Integrative Medicine Right for You?

TUESDAY, May 8, 2018 (HealthDay News) — Any approach that differs from conventional — or Western — medicine is typically considered complementary and alternative, or CAM. But these practices have become much more mainstream, leading to growth in the health care approach called integrative medicine, which draws on traditional and non-traditional systems tailored to each…

Generic Drugs Don't Always Push Prices Down

MONDAY, May 7, 2018 (HealthDay News) — Generic drugs tend to trigger big drops in the cost of their expensive, brand-name counterparts, but that has not been the case with the cancer drug commonly known as Gleevec (imatinib). There’s been only a small drop in the price of imatinib since a generic version was introduced…